CTRI/2018/10/016061
Not yet recruiting
未知
Study the impact of Pharmaceutical care on the Diabetic patients in a tertiary care hospital in South India
Divyashree0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
- Sponsor
- Divyashree
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Type 2 Diabetic patients above 18 years of age admitted in the in Department of Medicine at Kasturba Hospital, Manipal and DM patients glycosylated Hemoglobin should be more than 7%.
Exclusion Criteria
- •Type 1 Diabetic patients, Gestational diabetes, Bedridden patients and Patients who are not willing to participate in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
The effect of pharmaceutical care intervention on health care and the safety of medication use in hospitalized elderlyDrug-Related Side Effects and Adverse ReactionsMedication ErrorsE02.319RBR-34f2px4Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (USP)
Not yet recruiting
Not Applicable
Effects of Pharmaceutical Care on Medication Appropriateness in Elderly Patients Treated at Uttaradit HospitalTo evaluate the appropriateness of medicines use in elderly patients by comparison of prevalence of PIMs among patients receiving pharmacutical care with patients receiving regular medication servicesSTOPP version 2,Beers 2015,Potentially Inappropriate medication,ElderlyTCTR20181104004Faculty of Pharmacy, Chiang Mai Universit236
Not yet recruiting
Not Applicable
Pharmaceutical care services for diabetic foot ulcersHealth Condition 1: Z00-Z99- Factors influencing health status and contact with health servicesCTRI/2020/12/029603A
Not yet recruiting
Not Applicable
Impact of pharmaceutical care in schizophrenic patientsHealth Condition 1: F209- Schizophrenia, unspecifiedCTRI/2022/10/046427Dr Deepak C G
Active, not recruiting
Phase 1
Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant PatientsRenal TransplantationMedDRA version: 19.0Level: LLTClassification code 10023438Term: Kidney transplantSystem Organ Class: 100000004865Therapeutic area: Body processes [G] - Immune system processes [G12]EUCTR2016-001042-25-Outside-EU/EEAF. Hoffmann-La Roche AG720